Chantal Carrez

Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5-<i>c</i>]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone

François Vallée, Chantal Carrez, Fabienne Pilorge et al. · Journal of Medicinal Chemistry · 2011 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

An Antibody–Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities

Céline Nicolazzi, Anne Caron, Alexia Tellier et al. · Molecular Cancer Therapeutics · 2020 · 32 citations

Medicine, Oncology, Pharmacology +17

Development and Validation of an Immuno-PET Tracer as a Companion Diagnostic Agent for Antibody-Drug Conjugate Therapy to Target the CA6 Epitope

Ohad Ilovich, Arutselvan Natarajan, Sharon S. Hori et al. · Radiology · 2015 · 24 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment

Hélène Bonnevaux, S. Guérif, Jana D. Albrecht et al. · OncoImmunology · 2021 · 16 citations · Full text

Medicine, Immunology, Oncology +17

Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader

Laurent Besret, Sébastien d’Heilly, Cathy Aubert et al. · EJNMMI Research · 2020 · 14 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17